# NFIB_lung_cancer
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer. The transcription factor that is investigated in this experiment is NFIB. The antibody used is Bethyl NFIB antibody. The goal of this analysis is to look at the target genes of this transcription factor in HeLa cells.
